中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
29期
48-49
,共2页
玻璃体切割术%玻璃体积血%疗效%观察
玻璃體切割術%玻璃體積血%療效%觀察
파리체절할술%파리체적혈%료효%관찰
Vitrectomy%Vitreous hemorrhage%Efficacy%Observation
目的:分析玻璃体切割术对玻璃体积血的疗效及安全性。方法随机选择2010年1月—2015年5月该院收治的70例玻璃体积血患者,按照治疗方法不同,分为对照组(n=30)采用保守疗法,观察组(n=40)采用玻璃体切割术,对比两组治疗后矫正视力分布情况和并发症发生率。结果治疗后6个月与对照组相比,观察组矫正视力>0.6、0.5~0.6、0.25~0.3的眼数更多,<0.02的眼数更少(P<0.05)。观察组并发症发生率为20.00%低于对照组46.67%(P<0.05)。结论采用玻璃体切割术治疗玻璃体积血具有临床疗效好、安全性高等优点。
目的:分析玻璃體切割術對玻璃體積血的療效及安全性。方法隨機選擇2010年1月—2015年5月該院收治的70例玻璃體積血患者,按照治療方法不同,分為對照組(n=30)採用保守療法,觀察組(n=40)採用玻璃體切割術,對比兩組治療後矯正視力分佈情況和併髮癥髮生率。結果治療後6箇月與對照組相比,觀察組矯正視力>0.6、0.5~0.6、0.25~0.3的眼數更多,<0.02的眼數更少(P<0.05)。觀察組併髮癥髮生率為20.00%低于對照組46.67%(P<0.05)。結論採用玻璃體切割術治療玻璃體積血具有臨床療效好、安全性高等優點。
목적:분석파리체절할술대파리체적혈적료효급안전성。방법수궤선택2010년1월—2015년5월해원수치적70례파리체적혈환자,안조치료방법불동,분위대조조(n=30)채용보수요법,관찰조(n=40)채용파리체절할술,대비량조치료후교정시력분포정황화병발증발생솔。결과치료후6개월여대조조상비,관찰조교정시력>0.6、0.5~0.6、0.25~0.3적안수경다,<0.02적안수경소(P<0.05)。관찰조병발증발생솔위20.00%저우대조조46.67%(P<0.05)。결론채용파리체절할술치료파리체적혈구유림상료효호、안전성고등우점。
Objective To analyze the efficacy and safety of vitrectomy in the treatment of vitreous hemorrhage. Methods Seventy cases with vitreous hemorrhage admitted in our hospital from January 2010 to May 2015 were selected and divided into the control group (n=30) and the observation group (n=40). Patients in the control group were treated by conservative treatment, while those in the observation group were treated by vitrectomy. And the corrected visual acuity after treatment and incidence of complications were compared between the two groups. Results After six months of treatment, compared with the control group, the observation group had more eyes with corrected visual acuity> 0.6, 0.5-0.6, 0.25-0.3, and less eyes with corrected visual acuity <0.02 (P<0.05). The incidence of complications was much lower in the observation group than that in the control group (20.00% vs 46.67%) (P<0.05). Conclusion Vitrectomy has good clinical efficacy and high safety and other advantages in the treatment of vitreous hemorrhage.